Epigenetically mediated downregulation of the differentiation-promoting chaperon protein CRABP2 in astrocytic gliomas

Epigenetic Silencing of CRABP2 and MX1 in Head and Neck Tumors

(2015) Marilia F. Calmon et al.   NEOPLASIA

Aberrant Expression of Retinoic Acid Signaling Molecules Influences Patient Survival in Astrocytic Gliomas

(2011) Benito Campos et al.   AMERICAN JOURNAL OF PATHOLOGY

Differential Retinoic Acid Signaling in Tumors of Long- and Short-term Glioblastoma Survivors

(2011) Sebastian Barbus et al.   JNCI-Journal of the National Cancer Institute

Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma

(2010) Houtan Noushmehr et al.   CANCER CELL

Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells

(2010) B. Campos et al.   CLINICAL CANCER RESEARCH

Down-regulation of tumor suppressor a kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms

(2010) Benjamin Goeppert et al.   HEPATOLOGY

Glioma stem cells as a target for treatment

(2010) Katrin Lamszus et al.   Targeted Oncology

Derangement of a Factor Upstream of RARα Triggers the Repression of a Pleiotropic Epigenetic Network

(2009) Francesca Corlazzoli et al.   PLoS One

CD133 Expression and Cancer Stem Cells Predict Prognosis in High-grade Oligodendroglial Tumors

(2008) Dagmar Beier et al.   BRAIN PATHOLOGY

Expression of retinoic acid receptors in human endometrial carcinoma

(2008) Kojiro Tanabe et al.   CANCER SCIENCE

Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients

(2008) F. Zeppernick et al.   CLINICAL CANCER RESEARCH

Presence of pluripotent CD133+ cells correlates with malignancy of gliomas

(2008) Niklas Thon et al.   MOLECULAR AND CELLULAR NEUROSCIENCE